Macquarie raised the price target for the Surgery Partners Inc (NASDAQ:SGRY) stock to “an Outperform”. The rating was released on June 28, 2024, according to finviz. The research report from TD Cowen has upgraded the stock from Market Perform to Outperform, with a price target set at $35. The stock was upgraded by BofA Securities, who disclosed in a research note on June 02, 2023, from Neutral to Buy and set the price objective to $45. In their research brief published May 12, 2023, Mizuho analysts initiated the Surgery Partners Inc stock to Buy with a price target of $48.
The latest trade, Performances and Moving Averages give us the following Picture
The firm’s stock price fluctuated -9.21% within the last five trades and 23.18% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -10.64% in the last 6 months and 16.28% was added to its value over the previous 3 months. SGRY stock is trading at a margin of 3.89%, 10.75% and 1.73% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
Sponsored
As of the close of trading, SGRY deals in the Healthcare domain. The stock is trading -23.20 percent below its 52-week high and 31.84 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -16.3. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Surgery Partners Inc’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at 15.34 percent and the profit margin is 0.02 percent, and the company has reported a gross margin of 19.71 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $3.69 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for Surgery Partners Inc (NASDAQ:SGRY) is 9690.00. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 22.84. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1.32 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.88, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 43.06 percent of Surgery Partners Inc shares are owned by insiders, and 66.11 percent are held by financial institutions. Burkhalter Danielle, the Chief Human Resources Officer at Surgery Partners Inc (SGRY) has sold 6,000 shares of firm on Jun 12 ’24 at a price of $26.39 against the total amount of $0.16 million. In another inside trade, Owens Bradley R., National Group President of Surgery Partners Inc (NASDAQ:SGRY) sold 6,000 shares of the firm on May 31 ’24 for a total worth of $0.17 million at a price of $27.65. An inside trade which took place on Mar 14 ’24, Chief Financial Officer of Surgery Partners Inc Doherty David T sold 721 shares of firm against total price of $20613.0 at the cost of $28.59 per share.